Filing Details

Accession Number:
0001127602-14-007073
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-19 15:40:21
Reporting Period:
2014-02-14
Filing Date:
2014-02-19
Accepted Time:
2014-02-19 15:40:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456336 Gregory Stea 65 Hayden Avenue
Lexington MA 02421
Svp, Commercial Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-15 1,472 $0.00 15,661 No 4 M Direct
Common Stock Acquisiton 2014-02-16 1,600 $0.00 17,261 No 4 M Direct
Common Stock Disposition 2014-02-18 985 $75.00 16,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Acquisiton 2014-02-14 28,110 $0.00 28,110 $73.55
Common Stock Restricted Stock Units Acquisiton 2014-02-14 3,738 $0.00 3,738 $0.00
Common Stock Performance Restricted Stock Units Acquisiton 2014-02-14 3,738 $0.00 3,738 $0.00
Common Stock Restricted Stock Units Disposition 2014-02-15 1,472 $0.00 1,472 $0.00
Common Stock Restricted Stock Units Disposition 2014-02-16 1,600 $0.00 1,600 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,110 2014-05-14 2024-02-14 No 4 A Direct
3,738 2015-02-14 No 4 A Direct
3,738 2017-02-14 No 4 A Direct
4,417 2014-02-15 No 4 M Direct
3,200 2013-02-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 334 Indirect 401(k) Plan
Footnotes
  1. Sold pursuant to Rule 10(b)5-1 Plan.
  2. Shares were sold to cover tax obligations incurred in connection with the vesting of Restricted Stock Units.
  3. Option vests 6.25% quarterly over a four-year period.
  4. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
  5. The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.
  6. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
  7. Shares are earned based on the achievement of certain performance conditions, which are set forth in the applicable performance unit agreement. Any earned shares are delivered to the reporting person on the third anniversary of the grant date. The restricted stock units do not expire.